EHA Congratulates EHA Research Grants 2022 Recipients


The Hague, May 30, 2022 – EHA congratulates eight talented researchers in hematology on their receipt of the EHA Research Grants 2022 after a rigorous selection process.  

EHA Research Grants support talented early career researchers in advancing their career towards becoming leaders of research groups. These grants are intended for basic and translational lab-based research in hematology. Novel and relevant translational parts of a clinical trial can also be funded in compelling circumstances. 

"It is the dynamic interaction between research and patient care that provide the most fertile soil for the next generation of expert hematologists to thrive. The EHA research funding program is therefore of central importance to us. By granting support both for early carrier steps and advanced hematology research we connect highly talented researchers in the field and to EHA. We are working towards increasing our grant funding to make even larger contributions towards the future of hematology. This year we received an impressive number of outstanding applications covering many relevant topics in hematology. We congratulate all award winners for their successful applications and are looking forward to follow them become leaders in their field and contributing to the mission of EHA. says Professor Jean-Pierre Bourquin, Chair of the EHA Fellowships & Grants Committee.  

The Fellowships & Grants Committee would like to thank all applicants for the high quality of all proposals submitted and continue to encourage early career researchers, especially those from under represented countries, to apply to the 2023 edition which will open in the fall of 2022.  

Research Grants 2022 awardees are in institutes in France, Italy, the Netherlands, Spain, Sweden, and the United Kingdom. They join a network of over 120 distinguished researchers who have received EHA Funding in the past. 




Project Title 


 RG Alexandre Fagnan up

Alexandre Fagnan 


Junior Research Grant 

Deciphering the chromatin remodeling mechanism mediated by GATA2 ZnF1 mutations in AML. 

University of Oxford, UK 

 RG Samuele Ferrari UP

Samuele Ferrari 

Junior Research Grant 

Innovative targeted base editing strategies for gene correction of WHIM syndrome.  

Ospedale San Raffaele, Italy 

 RG Lars Velten up

Lars Velten 


Advanced Research Grant 

The role of the DNA methylation landscape in regulating HSC fate biases, fate restriction, and lineage differentiation.  

Centre for Genomic Regulation, Spain 

 RG Ozgen Deniz up

Özgen Deniz 


Advanced Research Grant 

Functional Interrogation of Transposable Elements in Paediatric Acute Myeloid Leukaemia.  

Imperial College London, UK  

 RG Emma de Pater up

Emma de Pater 

Advanced Research Grant 

Deconstructing the effect and timing of GATA2 haploinsufficiency driven leukemogenesis.  

Erasmus MC, the Netherlands 

 RG Berengere KOEHL up

Bérengère Koehl 

Physician Scientists’ Research Grant 

Abnormal Myelopoiesis in Sickle cell disease promotes neutrophils dysfunction, inflammation and early hematopoiesis ageing.  

Université de Paris, France 

The Topics-in-Focus program was launched by EHA to support hematologists in this rapidly developing scenario, aiming to raise awareness, provide education, further research, and build a network of experts in specific fast-growing areas. In 2022, EHA awarded two Topics-in-Focus grants meant for quality basic or translational research projects in the field of Immunotherapy. The talented recipients of these grants are from institutes in France and the Netherlands. 




Project Title 


 RG Anne Marijn Kramer up2

Anne Marijn Kramer 

Topic-in-Focus Junior Research Grant (Immunotherapy) 

Study of CAR T-Cell Associated Toxicity and Efficacy:Mechanisms, Clinicopathologic Correlates, and state-ofthe- art nanomedicine-based targeting of myeloid immune cells as a novel therapeutic strategy. 

Amsterdam University Medical Center, the Netherlands  

 RG Arnika Wagner

Arnika Wagner 

Topic-in-Focus Advanced Research Grant (Immunotherapy) 

Novel chimeric antigen receptors for optimized NK cell function.  

Karolinska Institutet, Sweden 

More information about the EHA grants program can be found at 

The European Hematology Association (EHA) promotes excellence in patient care, research, and education in hematology. EHA envisions a world without blood disorders by connecting hematologists worldwide, supporting their career development and research, harmonizing hematology education, and advocating the interests of hematology and hematologists in the European arena. 


Francesco Cerisoli, EHA Head of Research & Mentoring

Last Updated on Monday 30 May 2022.